HCA Holdings, Inc. (HCA) Position Trimmed by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC trimmed its holdings in shares of HCA Holdings, Inc. (NYSE:HCA) by 33.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,000 shares of the company’s stock after selling 17,500 shares during the period. Sivik Global Healthcare LLC’s holdings in HCA Holdings were worth $3,052,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Gotham Asset Management LLC increased its holdings in HCA Holdings by 178.5% during the 1st quarter. Gotham Asset Management LLC now owns 325,689 shares of the company’s stock valued at $28,983,000 after purchasing an additional 208,745 shares in the last quarter. Focused Wealth Management Inc increased its holdings in HCA Holdings by 52.6% during the 1st quarter. Focused Wealth Management Inc now owns 2,900 shares of the company’s stock valued at $258,000 after purchasing an additional 1,000 shares in the last quarter. Venturi Wealth Management LLC acquired a new stake in HCA Holdings during the 1st quarter valued at $6,109,000. Toronto Dominion Bank increased its holdings in HCA Holdings by 44.3% during the 1st quarter. Toronto Dominion Bank now owns 80,875 shares of the company’s stock valued at $7,197,000 after purchasing an additional 24,830 shares in the last quarter. Finally, State of Tennessee Treasury Department increased its holdings in HCA Holdings by 34.9% during the 1st quarter. State of Tennessee Treasury Department now owns 123,155 shares of the company’s stock valued at $10,960,000 after purchasing an additional 31,852 shares in the last quarter. 73.77% of the stock is owned by hedge funds and other institutional investors.

In other HCA Holdings news, insider Jonathan B. Perlin sold 71,063 shares of the stock in a transaction dated Thursday, June 22nd. The stock was sold at an average price of $86.00, for a total transaction of $6,111,418.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $79.88, for a total value of $171,742.00. Following the sale, the insider now owns 12,363 shares of the company’s stock, valued at $987,556.44. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 75,363 shares of company stock valued at $6,469,006. Company insiders own 2.90% of the company’s stock.

HCA Holdings, Inc. (HCA) traded down 0.79% on Friday, hitting $79.24. The stock had a trading volume of 2,451,655 shares. The company has a market capitalization of $28.63 billion, a PE ratio of 10.62 and a beta of 0.67. HCA Holdings, Inc. has a 12-month low of $67.00 and a 12-month high of $91.03. The company has a 50 day moving average of $78.63 and a 200 day moving average of $83.51.

HCA Holdings (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.80 by ($0.05). The company had revenue of $10.73 billion during the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.66 earnings per share. On average, equities analysts expect that HCA Holdings, Inc. will post $7.19 earnings per share for the current year.

HCA has been the subject of several research reports. Argus initiated coverage on HCA Holdings in a research note on Wednesday, June 28th. They issued a “buy” rating and a $100.00 target price for the company. ValuEngine cut HCA Holdings from a “buy” rating to a “hold” rating in a research note on Thursday, September 7th. BidaskClub cut HCA Holdings from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Bank of America Corporation cut HCA Holdings from a “buy” rating to a “neutral” rating and lowered their target price for the company from $102.00 to $92.00 in a research note on Wednesday, July 26th. Finally, Morgan Stanley initiated coverage on HCA Holdings in a research note on Tuesday, June 6th. They issued an “equal weight” rating and a $90.00 target price for the company. One analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $92.88.

ILLEGAL ACTIVITY NOTICE: “HCA Holdings, Inc. (HCA) Position Trimmed by Sivik Global Healthcare LLC” was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.chaffeybreeze.com/2017/09/17/hca-holdings-inc-hca-position-trimmed-by-sivik-global-healthcare-llc.html.

About HCA Holdings

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Institutional Ownership by Quarter for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply